Case Study: Virtual Pharmaceutical Stakeholders achieve FDA approval for an emergency-use combination product with Kymanox

A Kymanox Case Study

Comprehensive Support for an Emergency-Use Combination Product​

The customer, referred to as virtual pharmaceutical stakeholders, faced the challenge of developing an emergency-use combination product. They needed support with formulation optimization, clinical trial material manufacturing, and a scalable quality system to achieve FDA approval and commercial readiness. They engaged Kymanox for its integrated CMC, clinical, and regulatory strategy services.

Kymanox provided a comprehensive solution that included drafting the complete NDA, performing human factors assessments, and establishing an electronic quality management system. The results were exceptional, with Kymanox delivering FDA approval and ensuring the life-saving therapy reached the market through established commercial manufacturing capabilities and a compliant infrastructure.


View this case study…

Kymanox

58 Case Studies